bloating and semaglutide 20 Ozempic Wegovy Side Effects You Should Know About Ozempic Sulfur Burps & Bloating:

Association of glucagon-like peptide-1 receptor agonists with cardiac arrhythmias in patients with type 2 diabetes or obesity: a systematic review and meta-analysis of randomized controlled trials

Unlike semaglutide (Ozempic/Wegovy), which targets a single receptor (GLP-1), or tirzepatide (Mounjaro/Zepbound), a dual agonist for GLP-1 and GIP receptors, retatrutide goes one step further and acts as a triple agonist targeting GLP-1, GIP and glucagon receptors

This is the highest average weight loss of any GLP-1 class medication tested to date

For example, due to our relatively small sample size we did not separate and analyze the volumes of strokes occurring in a particular vascular distribution

Xin et al

Diabetes 61 , 187196 (2012)